Daily non-political popular news in brief.

High-power MRI helps Mayo Clinic surgical team predict outcomes in unusual tumor cases

A Mayo Clinic surgical team has found that using a 3-Tesla MRI in surgical decision making provides a new level of capability to predict surgical outcomes that improves patient care by minimizing the potential for unsuccessful tumor-removal surgeries. The Mayo Clinic report appears in the December issue of the Journal of Neurosurgery.

Read more »

Keywords: high-power, mri, mayo, clinic, surgical, team, predict, outcomes, unusual, tumor, cases, high, power, outcome, case

« Previous | Next »

Similar news on "High-power MRI helps Mayo Clinic surgical team predict outcomes in unusual tumor cases":

1. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
   08-15-2007 · EurekAlert!
   A team of Mayo Clinic researchers has discovered a new, more accurate diagnostic test to detect infection of prosthetic joints, potentially leading to better treatment options and patient outcomes.
   Similar news · Read more »
   
2. Mayo Clinic shows therapy effective for reducing lupus flares
   11-09-2007 · EurekAlert!
   Mayo Clinic researchers have shown that an immunosuppressive drug used in organ transplant cases is effective in reducing flare-ups in patients with systemic lupus erythematosus. SLE results in inflammation of connective tissues and can involve the skin, joints and kidneys. Its cause is unknown. The findings were announced today at the annual meeting of the American College of Rheumatology in Boston.
   Similar news · Read more »
   
3. MIT aims to optimize chip designs
   08-16-2007 · Massachusetts Institute of Technology (MIT)
   Variations in miniiscule computer chips can cause fluctuations in circuit speed and power. An MIT research team is working to predict the variation in circuit performance and maximize the number of chips working within the chips' specifications.
   Similar news · Read more »
   
4. Clinical trials for diabetes drugs should measure outcomes important to patients
   09-27-2007 · EurekAlert!
   Most clinical trials for new diabetes drugs do not consider the impact medication will have on a patient's quality of life or other outcomes that are important to patients, such as the risk of developing complications associated with diabetes, according to a Mayo Clinic commentary in the current issue of the Lancet.
   Similar news · Read more »
   
5. Survival shortened when ER/PR negative breast cancer spreads to the brain
   12-16-2007 · EurekAlert!
   Two studies from Mayo Clinic's site in Jacksonville, Fla., of women whose breast cancer spread to their brain, have found that women whose tumors do not have estrogen or progesterone receptors have the worst overall outcomes. Because of this, these patients should be treated aggressively after an initial diagnosis to help prevent such a metastasis, say the investigators, who presented their findings at the San Antonio Breast Cancer Symposium.
   Similar news · Read more »
   
6. Mayo discovers protein as potential tactic to prevent tumors
   10-12-2006 · EurekAlert!
   Mayo Clinic researchers have found that a protein that initiates a "quality control check" during cell division also directs cell death for those cells damaged during duplication. This knowledge represents a potential "bulls eye" for targeting anti-tumor drugs. The findings appear in the current issue of Science.
   Similar news · Read more »
   
7. Mayo Clinic solves painful puzzle of UT ligament split tear in wrist
   04-11-2007 · EurekAlert!
   A Mayo Clinic orthopedic surgeon has discovered a common cause of debilitating wrist pain -- a split tear of the UT ligament -- that can be reliably detected through a simple physical examination and can be fully repaired through an arthroscopically guided surgical procedure. The findings are published in the April issue of the American Journal of Hand Surgery.
   Similar news · Read more »
   
8. SinuNase Phase 3 show almost 100 percent of chronic sinusitis cases are from fungal-induced inflamma
   09-10-2007 · EurekAlert!
   Accentia Biopharmaceuticals announces evidence that most, if not all cases of chronic sinusitis, are due to a fungal-induced inflammation as originally proposed by investigators at the Mayo Clinic. The data were collected as part of the company's ongoing pivotal phase 3 clinical trial for its lead pharmaceutical product, SinuNase™, an intranasal formulation of the antifungal amphotericin B 0.01 percent suspension.
   Similar news · Read more »
   
9. Mayo Clinic researchers use 'genomic pathway' to predict Parkinson's
   06-14-2007 · EurekAlert!
   A new Mayo Clinic study provides strong evidence that the joint effects of common DNA variations in several genes that encode proteins within a well-defined biological pathway largely explain why some persons get Parkinson's disease while others don't, and even predict with great accuracy at what age people might develop their first symptoms.
   Similar news · Read more »
   
10. Researchers train the immune system to deliver virus that destroys cancer in lab models
    12-18-2007 · EurekAlert!
    An international team of researchers led by Mayo Clinic have designed a technique that uses the body's own cells and a virus to destroy cancer cells that spread from primary tumors to other parts of the body through the lymphatic system.
    Similar news · Read more »